“Bimekizumab 4-year Efficacy in High-impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from BE BRIGHT”, J of Skin, vol. 8, no. 6, p. s432, Nov. 2024, doi: 10.25251/skin.8.supp.432.